The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Pharma Funding For Medical Classes Draws Scrutiny

July 29, 2009 7:36 am | News | Comments

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — A government watchdog will tell Congress Wednesday that the pharmaceutical and medical device industries' billion-dollar spending spree for medical education is threatening the judgment of physicians across the country. Nearly all U.S.


Oklahoma Board of Health Member And Pharmacist Faces Drug Charges

July 29, 2009 4:53 am | News | Comments

SEAN MURPHY Associated Press Writer OKLAHOMA CITY (AP) — A prominent pharmacist on the State Board of Health was accused in an indictment unsealed Tuesday of knowingly selling drugs used to make methamphetamine, prompting the governor to call for his resignation. Haskell Lee Evans Jr.


FDA Warns About Supplements With Steroids

July 29, 2009 4:50 am | News | Comments

EDDIE PELLS AP National Writer The FDA issued a public health advisory Tuesday, warning consumers to stop using products touted as containing steroids or steroid-like substances, many of which are labeled as dietary supplements.


MVI and Crucell Announce Collaboration For New Malaria Vaccine Approach

July 29, 2009 4:46 am | News | Comments

The U.S.-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP) and Dutch biopharmaceutical company Crucell N.V.


Sanofi-Aventis Second Quarter Profit Up 5 Percent

July 29, 2009 4:37 am | News | Comments

GREG KELLERAP Business WriterPARIS (AP) — Sanofi-Aventis reported Wednesday a 5 percent increase in second-quarter net profit, due to stronger sales of its diabetes drug Lantus and blood thinners Lovenox and Plavix, which it predicted would boost full-year earnings.


Bayer Second-Quarter Profit Slips Seven Percent

July 29, 2009 4:33 am | News | Comments

BERLIN — German pharmaceutical and chemical company Bayer AG said Wednesday that its second-quarter profit slipped seven per cent as sagging sales for its plastics division offset better results from its health-care products.


Philippine President Oorders Drug Prices Lowered

July 29, 2009 4:28 am | News | Comments

TERESA CEROJANO Associated Press Writer MANILA, Philippines (AP) — The Philippine president, bowing to pressure to reduce the cost of critical medicines, has slashed the price of five essential drugs by half, after pharmaceutical manufacturers ignored an appeal to do so voluntarily.


Mylan Names Heather Bresch President

July 29, 2009 4:25 am | News | Comments

PITTSBURGH (AP) — Mylan Inc. said Wednesday it promoted chief operating officer Heather Bresch to the post of president. Rajiv Malik will succeed Bresch as chief operating officer.


Valeant to Acquire Mexican Generic Company Tecnofarma

July 29, 2009 4:22 am | News | Comments

ValeantPharmaceuticals International has signed adefinitive Sale and Purchase Agreement to acquire Tecnofarma S.A. de C.V., aprivately held company located in Mexico for approximately one times sales.

FDA Asks Shire For More Info on ADHD Drug Candidate

July 28, 2009 12:00 pm | News | Comments

NEW YORK (AP) — Shire PLC said Tuesday the FDA asked the company for more information on developing attention-deficit hyperactivity disorder drug Intuniv, but did not identify safety concerns or ask for more studies.


Tablet Inspection Machine Provides Rapid And Reliable Analysis

July 28, 2009 11:36 am | Product Releases | Comments

The PharmaLIBS™ 250 tablet inspection machine is a laser-based analytical instrument designed for testing solid and oral dosage pharmaceuticals. It is a mobile and user-friendly tool for quick decision-making.

Mylan, FDA Disagree on Quality Control Inquiry

July 28, 2009 9:51 am | News | Comments

NEW YORK (AP) — Generic drug developer Mylan Inc. said Tuesday the FDA backed up the company's position that employees at a West Virginia facility did not ignore quality control procedures, though the agency disputes the company's claim.


FDA Says Schering-Plough's Experiemental Psychiatric Drug Appears Safe And Effective

July 28, 2009 8:08 am | News | Comments

MATTHEW PERRONE AP Business Writer WASHINGTON (AP) — Federal health regulators said Tuesday an experimental psychiatric drug from Schering-Plough Corp. appears to be a safe and effective treatment for patients with schizophrenia and bipolar disorder.


FDA Approves Two New Doses Of Medicis' Acne Treatment

July 28, 2009 8:03 am | News | Comments

NEW YORK (AP) — Shares of Medicis Pharmaceutical Corp. advanced Tuesday after the company said regulators approved two new doses of its top drug, the acne treatment Solodyn. Medicis said the Food and Drug Administration approved 65 mg and 115 mg doses of acne drug Solodyn.


Abbott to Acquire Wockhardt Nutrition Businesses, Expanding Presence in India

July 28, 2009 5:50 am | News | Comments

Abbott has announced a definitive agreement to acquire the nutrition businesses of WockhardtLimited, Carol Info Services Limited, and certain Wockhardt subsidiaries andgroup companies for consideration totaling approximately US$130 million incash.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.